Clinical trials: CHILDHOOD RHEUMATOID FEVER

SECONDARY PULMONARY HYPERTENSION, MITRAL STENOSIS

Bosentan for Severe Mitral Valve Dysfunction

• Unknown status
• Age: 60 to 85 years
• Phase 1/2

Vasoconstrictive signaling via endothelin receptors is not limited to primary pulmonary arterial hypertension, but has also been documented in secondary pulmonary hypertension due to congestive heart failure, including cardiac…

Conditions

SECONDARY PULMONARY HYPERTENSION, MITRAL STENOSIS, CHILDHOOD RHEUMATOID FEVER, CONGESTIVE HEART FAILURE

Trial name

BOSMIVAR (NCT01270750)

Testing

BOSENTAN

Where

Greece

Volunteers

10 people

Sponsor

General Hospital of Chalkida